These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2548493)

  • 1. Elevation of c-myc transcript level in human liver during surgical resection of hepatocellular carcinoma: possible cause for underestimation of c-myc gene activation in the tumor.
    Hayashi H; Taira M; Tatibana M; Tabata Y; Isono K
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1260-4. PubMed ID: 2548493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of oncogenes in human liver disease.
    Himeno Y; Fukuda Y; Hatanaka M; Imura H
    Liver; 1988 Aug; 8(4):208-12. PubMed ID: 2843721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas.
    Arbuthnot P; Kew M; Fitschen W
    Anticancer Res; 1991; 11(2):921-4. PubMed ID: 1648336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
    Ji F; Zhang ZH; Zhang Y; Shen SL; Cao QH; Zhang LJ; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2018 Apr; 18(1):460. PubMed ID: 29690860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the expression of oncogene mRNA in hepatocellular carcinoma using in situ hybridization technique].
    Hayashi D
    Nihon Geka Gakkai Zasshi; 1994 Nov; 95(11):814-22. PubMed ID: 7830708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway.
    Xia S; Ma J; Bai X; Zhang H; Cheng S; Zhang M; Zhang L; Du M; Wang Y; Li H; Rong R; Shi F; Yang Q; Leng J
    Oncol Rep; 2014 Oct; 32(4):1521-30. PubMed ID: 25109834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
    Wu B; Wang M; You W; Yang S
    Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue.
    Ljubimova JY; Petrovic LM; Wilson SE; Geller SA; Demetriou AA
    J Histochem Cytochem; 1997 Jan; 45(1):79-87. PubMed ID: 9010472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
    Ikeguchi M; Hirooka Y
    Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.
    Li L; Jin R; Zhang X; Lv F; Liu L; Liu D; Liu K; Li N; Chen D
    Hepatology; 2012 Oct; 56(4):1380-90. PubMed ID: 22706665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization].
    Yang S; Wang M; You W
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):415-7. PubMed ID: 8697990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.
    Fu XY; Wang HY; Tan L; Liu SQ; Cao HF; Wu MC
    World J Gastroenterol; 2002 Aug; 8(4):638-43. PubMed ID: 12174370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expressions of h-TERT, c-myc, PCNA and cell apoptosis in liver carcinogenesis].
    Fu XM; Yang QX; Shao CK; Feng ZY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):821-3. PubMed ID: 16793609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma.
    Yuen MF; Wu PC; Lai VC; Lau JY; Lai CL
    Cancer; 2001 Jan; 91(1):106-12. PubMed ID: 11148566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
    Zhang XK; Huang DP; Qiu DK; Chiu JF
    Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma.
    Liu D; Dong L; Liu Y; Wen D; Gao D; Sun H; Fan J; Wu W
    Tumour Biol; 2016 Apr; 37(4):5039-47. PubMed ID: 26546431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.